PMC9892716_01
Symptoms, diagnosis, and treatment of a reported patient. ARDS, acute respiratory distress syndrome; HFNC, high-flow nasal cannula; TPE, therapeutic plasma exchange.
fcvm-09-1035896-g0001.jpg
PMC9892716_01_fcvm-09-1035896-g0001.jpg
F1
He did not experience dyspnea after 5 days of HFNC treatment with flow decreased from 40 to 15 L/min; he was then switched to a nasal cannula with 5 L/min, then 3 L/min, and finally stopped oxygen therapy on day 14 (Figure 1).